Skip to content
cccskills
FreePublished on GitHub

enda-prednisolone-alternative-glucocorticoid

Suggests using prednisolone 3–5 mg/d orally once or twice daily as a glucocorticoid alternative in primary adrenal insufficiency. Consider this option when evaluating glucocorticoid therapy, particularly in patients with reduced medication compliance.

The English summary is being prepared. Showing the original description.

Run score Not tested

See how to install

Files included (1)

  • SKILL.md2.3 KB

SKILL.md (original)

Review the instructions the agent will receive before you install.

Use Prednisolone as Glucocorticoid Alternative with Specific Dosing

STEP 1 — Gather Information

Confirm diagnosis of primary adrenal insufficiency via ACTH stimulation test; assess current glucocorticoid regimen and adherence; evaluate need for mineralocorticoid replacement; review for pregnancy or other special considerations. If PAI is confirmed and glucocorticoid replacement is indicated, proceed to assess compliance.

STEP 2 — Rule In / Rule Out

Is the patient non‑adherent or experiencing reduced compliance with multiple‑dose glucocorticoid therapy? If yes, proceed to consider prednisolone; if no, continue with standard hydrocortisone regimen.

STEP 3 — Classify or Stratify

Select prednisolone dose 3–5 mg/d; choose once daily for simplicity or twice daily for more stable levels based on patient preference and lifestyle.

STEP 4 — Decide

Prescribe prednisolone 3–5 mg/d orally once or twice daily; ensure adequate fludrocortisone replacement if mineralocorticoid deficiency present; educate on adherence and stress dosing; schedule follow‑up in 4 weeks.

Clinical Guardrails / Mimics / Pitfalls

Prednisolone has reduced mineralocorticoid activity, so may require increased fludrocortisone; avoid in children (synthetic long‑acting glucocorticoids not recommended); do not use as sole glucocorticoid if mineralocorticoid replacement is inadequate; monitor for Cushingoid signs (weight gain, insomnia, edema); avoid dexamethasone due to higher Cushingoid risk.

Concrete Clinical Example

A 45‑year‑old woman with PAI on hydrocortisone 20 mg BID reports frequent missed doses; switched to prednisolone 4 mg once daily with fludrocortisone 100 µg daily; adherence improved and symptoms stable at 4‑week follow‑up.

Source: Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2015-1710

TODO: consider adding scripts/calc.py for the enda-prednisolone-alternative-glucocorticoid calculator

Reviews

No reviews yet. Tell others what you thought.

Comments

No login needed. Share how it worked for you, ask a question, or note where it did not run.

No comments yet. Be the first to write one.

Comments are published right away. Do not include personal information such as email addresses or phone numbers. Up to 2 URLs.

0 / 1,000 characters

This form is protected by reCAPTCHA, and the Google Privacy Policy and Terms of Service apply.

More skills from this repository

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

See all skills by dromlakhani

Report a problem with this skill